Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies

Antiviral Research - Tập 133 - Trang 218-222 - 2016
Robert W. Cross1,2, Chad E. Mire1,2, Luis M. Branco3, Joan B. Geisbert1,2, Megan M. Rowland3, Megan L. Heinrich3, Augustine Goba4,5, Mambu Momoh4,5,6, Donald S. Grant4,5, Mohamed Fullah4,5, Sheik Humarr Khan4,5, James E. Robinson7, Thomas W. Geisbert1,2, Robert F. Garry3,8
1Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, TX, USA
2Galveston National Laboratory, University of Texas Medical Branch at Galveston, Galveston, TX, USA
3Zalgen Labs, LLC, Germantown, MD, USA
4Viral Hemorrhagic Fever Program, Kenema Government Hospital, Kenema, Sierra Leone
5Ministry of Health and Sanitation, Freetown, Sierra Leone
6Polytechnic College, Kenema, Sierra Leone
7Sections of Infectious Disease, Departments of Pediatrics and Internal Medicine, School of Medicine, Tulane University, New Orleans, LA, USA
8Department of Microbiology and Immunology, Tulane University, New Orleans, LA, USA

Tài liệu tham khảo

Amorosa, 2010, Imported Lassa fever, Pennsylvania, USA, 2010, Emerg. Infect. Dis., 16, 1598, 10.3201/eid1610.100774 Bausch, 2010, Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever, Clin. Infect. Dis., 51, 1435, 10.1086/657315 Cummins, 1991, Exchange transfusion of a patient with fulminant Lassa fever, Postgrad. Med. J., 67, 193, 10.1136/pgmj.67.784.193 Fichet-Calvet, 2009, Risk maps of Lassa fever in west Africa, PLoS Negl. Trop. Dis., 3, e388, 10.1371/journal.pntd.0000388 Haas, 2003, Imported Lassa fever in Germany: surveillance and management of contact persons, Clin. Infect. Dis., 36, 1254, 10.1086/374853 Hirabayashi, 1989, The first imported case of Lassa fever in Japan, Nihon Rinsho, 47, 71 Ibekwe, 2012, Lassa fever: the challenges of curtailing a deadly disease, Pan Afr. Med. J., 11, 55 Jahrling, 1985, Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization, Trans. R. Soc. Trop. Med. Hyg., 79, 380, 10.1016/0035-9203(85)90388-8 Leifer, 1970, Lassa fever, a new virus disease of man from west Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease, Am. J. Trop. Med. Hyg., 19, 677, 10.4269/ajtmh.1970.19.677 McCarthy, 2014, US signs contract with ZMapp maker to accelerate development of the Ebola drug, BMJ, 349, g5488, 10.1136/bmj.g5488 Mejias, 2008, Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants, Biologics, 2, 433 Robinson, 2016, Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits, Nat. Commun., 7, 11544, 10.1038/ncomms11544 Safronetz, 2015, The broad-spectrum antiviral favipiravir protects Guinea pigs from lethal Lassa virus infection post-disease onset, Sci. Rep., 5, 14775, 10.1038/srep14775 Shaffer, 2014, Lassa fever in post-conflict Sierra Leone, PLoS Negl. Trop. Dis., 8, e2748, 10.1371/journal.pntd.0002748 Stephenson, 1984, Effect of environmental factors on aerosol-induced Lassa virus infection, J. Med. Virol., 14, 295, 10.1002/jmv.1890140402 WHO, 2016
Thông tin
Thông tin xuất bản

Antiviral Research

Tập 133

218-222

Thông tin tác giả